An Active Surveillance Study to Monitor the Real-World Safety of Ritlecitinib Among Patients with Alopecia Areata in Denmark, France, and Sweden

21/05/2025
02/11/2026
EU PAS number:
EUPAS1000000512
Study
Planned

ENCePP Code of conduct

No information provided.
Data sources

Data source(s)

Data source(s), other

Denmark's population-based registers
Sweden's population-based registers
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

No

Check completeness

No

Check stability

No

Check logical consistency

No
Data characterisation

Data characterisation conducted

No
Procedures
No information provided.